Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2019

Sep 10, 2019

30786_dirs_2019-09-10_3c1accff-aa30-4f00-bfc1-2de8b0c97f2d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO, BIOB)
CIK: 0000012208
Period of Report: 2019-09-09

Reporting Person: HERTIA JOHN (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-09-09 Bio-Rad A Common Stock M 600 $159.32 Acquired 18206 Direct
2019-09-09 Bio-Rad A Common Stock S 444 $336.47 Disposed 17762 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-09-09 Non-Qualified Stock Option (right to buy) $159.32 M 600 Disposed 2026-09-07 Bio-Rad A Common Stock (600) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 252 Indirect

Footnotes

F1: The option vests in five equal annual installments beginning September 7, 2017.